The Week

HONA.US fell 2.95% this week to close at $158.78, while the S&P 500 rose 1.21%, leaving the stock about 4.16 percentage points behind the benchmark. The price action was a fade from the highs: after opening at $163.85 on Monday (21 Sep), the stock touched an intraday week high of $170.32, then slid over the next three sessions. It closed at $158.46 on Thursday (24 Sep) and dipped to $156.74 on Friday (25 Sep) before recovering to $158.78. The week’s amplitude was 8.29%, and turnover came in about 4% below the median daily volume.

Key Events

The main theme of the week was litigation. On Tuesday (22 Sep), reports said Honeywell Aerospace filed patent lawsuits against Rivian and Lucid, the only clear business-side announcement during the period. Over the following days, several law firms issued securities class-action notices against the company, including Glancy Prongay Wolke & Rotter, Kirby McInerney, DJS Law Group, and Kahn Swick & Foti, with the latter flagging 23 November 2026 as the application deadline. The incremental news flow was limited, but the litigation-related alerts added pressure to the share price.

Analyst Ratings

Among the 16 institutions covering the stock, 4 rate it buy, 2 rate it over, and 10 rate it hold, with none at under or sell. The consensus recommendation is buy, and the consensus target of $209.50 sits about 31.94% above the spot price of $158.78. The target range runs from $175 to $256, pointing to wide dispersion across brokers. Within the aerospace and defence industry, the stock ranks 18th out of 85 names, placing it in the upper-middle tier.

The Week Ahead

Macro data picks up in the coming days: Monday (28 Sep) brings the Dallas Fed manufacturing business activity index, previously at 11.6. Tuesday (29 Sep) is busier, with FHFA house prices, the Case Shiller 20-city home price index, JOLTS job openings (prior 7.271, forecast 7.24), and the consumer confidence index (prior 89.4, forecast 90) all due. The litigation thread from this week remains open, though the November deadline cited in several notices does not create an immediate catalyst.

In Short

The stock lagged the market this week, yet the consensus rating remains buy and the consensus target is roughly a third above spot, leaving a tension between broker positioning and price action. On valuation, P/E sits at 25.86x and the price is close to the 20-day average of $159.83, while the 60-day average stands near $182.50. The latest session’s capital flow shows large and medium orders as net buyers and small orders as net sellers, tilting upward without evidence of persistence. The next things to watch are any fresh developments in the securities litigation and how the dense macro calendar reshapes risk appetite.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.